Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05449002 · ClinicalTrials.gov registry record · NA

Digital Single Session Intervention for Youth Mental Health

A NA study of Depression and Anxiety, sponsored by Harvard University.

Recruiting
Registry status
NA
Development phase
226
Enrollment target
5
Study locations

NCT05449002: Recruiting NA study of Depression and Anxiety, sponsored by Harvard University.

NCT05449002 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Harvard University. The registered enrollment target is 226 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05449002, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Harvard University.

RECRUITING
Registry status
NA
Development phase
226 participants
Enrollment target
5
Study locations

Study Summary

The aim of this study is to test the effectiveness of a single-session, digital intervention teaching the principle of practicing the opposite, when administered to youths on the waitlist for psychotherapy, with usual waitlist procedures as a control condition.

Primary Outcome

Assesses the child's thoughts and feelings over the past week using both youth and parent report. Both the youth and parent report surveys include 12 items each scored from 04, with higher scores indicating more severe symptoms. Consists of an internalizing and externalizing subscale, the trajectories of which will be analyzed separately and compared between the intervention and control group. Note that timing described below may be adjusted if response or feedback suggests excessive measurement

Interventions

  • BEHAVIORAL Practicing the Opposite (PTO)
  • OTHER Usual Clinical Care

Study Locations (5)

Massachusetts

  • Boston Child Study Center - Boston
  • The Baker Center for Children and Families - Boston
  • The Concord Center - Concord
  • Riverside Community Care - Dedham

Indiana

  • Riley Child Psychiatry and Behavioral Sciences Clinic - Indianapolis

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2022-09-05
Est. Completion 2027-09-30
Phase NA
Harvard University

37 total trials

What NCT05449002 shows while recruiting

NCT05449002 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Practicing the Opposite (PTO) is the first listed.

NCT05449002 lists 5 locations in 2 states (Massachusetts, Indiana).

Frequently Asked Questions

What is clinical trial NCT05449002 about?

NCT05449002 is a clinical study titled "Digital Single Session Intervention for Youth Mental Health". The aim of this study is to test the effectiveness of a single-session, digital intervention teaching the principle of practicing the opposite, when administered to youths on the waitlist for psychotherapy, with usual waitlist procedures as a control condition.

What is the current status of trial NCT05449002?

This trial is currently recruiting. It is a NA study. The enrollment target is 226 participants. The study started on 2022-09-05. Estimated completion is 2027-09-30.

What conditions does trial NCT05449002 study?

This clinical trial studies the following conditions: Depression, Anxiety, Stress, Conduct Disorder.

What interventions are being tested in trial NCT05449002?

The interventions under investigation include: Practicing the Opposite (PTO) (BEHAVIORAL), Usual Clinical Care (OTHER).

Who is sponsoring clinical trial NCT05449002?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05449002 being conducted?

This trial has 5 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05449002's enrollment target sits among peer trials

226 192nd of 679 higher than 486 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

  • NCT06106945 · 226 participants · Phase 1

    AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05449002, the US trial registry maintained by the National Library of Medicine. NCT05449002 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.